Global Gene Panel Market to Reach $8.8 Billion by 2030
The global market for Gene Panel estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$8.8 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2022-2030. Test Kits, one of the segments analyzed in the report, is projected to record 18.2% CAGR and reach US$5.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Testing Services segment is readjusted to a revised 22.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $611 Million, While China is Forecast to Grow at 18.5% CAGR
The Gene Panel market in the U.S. is estimated at US$611 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 18.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 17% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.Select Competitors (Total 47 Featured) -
- Agilent Technologies, Inc.
- ArcherDX, Inc.
- Eurofins Scientific SE
- F. Hoffmann-La Roche AG
- GATC Biotech AG
- GENEWIZ
- Illumina, Inc.
- Integrated DNA Technologies (IDT), Inc.
- Personalis, Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Gene Panel: A Prelude
- Gene Panel - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
3. MARKET TRENDS & DRIVERS
- Gene Panel Methods
- Gene Panel Analysis and the Exome Analysis
- Evaluation of Gene Panel
- Cancer Gene Panels
- Multi-Gene Panel Testing
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Gene Panel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World 8-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 4: World 8-Year Perspective for Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 6: World 8-Year Perspective for Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Cancer Risk Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World 8-Year Perspective for Cancer Risk Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Diagnosis of Congenital Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 10: World 8-Year Perspective for Diagnosis of Congenital Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 12: World 8-Year Perspective for Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 16: World 8-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 18: World 8-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 19: World Gene Panel Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
UNITED STATES
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Active Players in United States
- Table 22: USA Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 23: USA 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 24: USA Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 25: USA 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
CANADA
- Active Players in Canada
- Table 28: Canada Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: Canada 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 30: Canada Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: Canada 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Canada 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
JAPAN
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Active Players in Japan
- Table 34: Japan Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: Japan 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 36: Japan Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: Japan 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Japan 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
CHINA
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Active Players in China
- Table 40: China Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: China 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 42: China Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: China 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: China 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
EUROPE
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 46: Europe Recent Past, Current & Future Analysis for Gene Panel by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 47: Europe 8-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 48: Europe Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: Europe 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Europe 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 52: Europe Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: Europe 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
FRANCE
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Active Players in France
- Table 54: France Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: France 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 56: France Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: France 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 58: France Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: France 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
GERMANY
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Active Players in Germany
- Table 60: Germany Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: Germany 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 62: Germany Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Germany 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 64: Germany Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Germany 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
ITALY
- Active Players in Italy
- Table 66: Italy Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Italy 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 68: Italy Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Italy 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 70: Italy Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Italy 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
UNITED KINGDOM
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Active Players in United Kingdom
- Table 72: UK Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: UK 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 74: UK Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: UK 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 76: UK Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: UK 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
REST OF EUROPE
- Active Players in Rest of Europe
- Table 78: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: Rest of Europe 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Rest of Europe 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 83: Rest of Europe 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
ASIA-PACIFIC
- Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Active Players in Asia-Pacific
- Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 85: Asia-Pacific 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Asia-Pacific 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 89: Asia-Pacific 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
REST OF WORLD
- Active Players in Rest of World
- Table 90: Rest of World Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 91: Rest of World 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
- Table 92: Rest of World Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of World 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
- Table 94: Rest of World Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 95: Rest of World 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- ArcherDX, Inc.
- Eurofins Scientific SE
- F. Hoffmann-La Roche AG
- GATC Biotech AG
- GENEWIZ
- Illumina, Inc.
- Integrated DNA Technologies (IDT), Inc.
- Personalis, Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 8.8 Billion |
| Compound Annual Growth Rate | 19.6% |
| Regions Covered | Global |
